Board summary
Key figures
35,505
Registered population
69.5% aged 18–64
16.5%
Aged 65+
ICB 21.9% · England 17.9%
15.3%
Ethnic minority (non-White)
5.2% Asian · England 9.6%
27.8%
In IMD quintile 1
ICB 9.2% · England 21.0%
~8,177
Core20 residents (est.)
Resident basis; registered basis ~10,460 · see page 3
3,893
Hypertension register
+10.77% in 3 yrs · England +5.60%
493
SMI register
10.6% of Brighton and Hove (LAD)'s
596
COPD register
Reviews +7.24% in 3 yrs
Forecast to 2030
4,746
Hypertension patients, 2030
+853 on today
74.2%
QRISK ≥20% on statins, 2030
+5.40pp over 3 yrs
4.1%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Wide practice spread in phone access.
Phone contact ease spans from 19.1% at The Avenue Surgery to 81.8% at Ship Street Surgery (England 56.9%), which may reflect unverified capacity differences.
Asthma reviews and cancer screening lag England.
Asthma review coverage is 62.8% (England 65.7%), while cervical screening (25-49 yrs) is 54.8% (England 66.8%) and breast screening is 61.9% (England 69.9%).
High BP recording, lower treatment conversion.
Hypertension BP recording reaches 94.1% (England 90.0%), though treatment to target (69.0% vs 70.3%) and high-risk lipid therapy (61.8% vs 63.6%) trail England.
Population, age and ethnicity
Working-age adults form 69.5% of registered patients alongside 5,868 patients aged 65+
Dean's and Central Brighton PCN serves 35,505 registered patients across five practices. Working-age adults aged 18-64 represent 69.5% of the list, below Brighton and Hove (LAD) at 71.4% but above NHS Sussex Integrated Care Board (60.5%) and England (62.7%). Older adults aged 65+ make up 16.5% (5,868 patients), above the LAD (14.0%) but below the ICB (21.9%) and England (17.9%). Children aged 0-17 comprise 13.9% (LAD 15.0%, ICB 17.7%, England 19.6%). Census figures show 84.7% of local residents are White (LAD 85.4%, ICB 91.0%, England 81.1%), which reflects area residents rather than registered patients.
Age profile
65+: ICB 21.9%, England 17.9%
Ethnicity
Older people · falls rows are Brighton and Hove (LAD) local-authority (LA) data, not PCN
| Measure | Local | South East | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Brighton and Hove LA) | 2,702 | 2,018 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 76.6% | 82.2% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 57.1% | 57.8% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Brighton and Hove LA) | 1,485 | 981 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Brighton and Hove LA) | 19.9 | 14.0 | 14.8 | 2022‑24 |
Deprivation and Core20
Core20 share reaches 27.8% but spans 59.6 percentage points across practices
The PCN Core20 cohort is 27.8%, above Brighton and Hove (LAD) at 17.6%, NHS Sussex Integrated Care Board at 9.2% and England at 21.0%. An average IMD decile of 5.1 masks a 59.6 pp practice spread, ranging from Saltdean And Rottingdean Med Practice at 0.9% to The Avenue Surgery at 60.5%. Practice-level registered estimates sum to 10,460 patients, while the PCN resident estimate is 8,177. Prioritising inequality outreach requires balancing concentration at The Avenue Surgery (3,912 patients) against absolute volume at Brighton Station Health Centre (3,174 patients).
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
493
SMI register
1.35% recorded prevalence
211
Learning disability register
0.58% recorded prevalence
19
Care homes, 484 beds
In the PCN catchment
8.2%
Provide unpaid care
Brighton and Hove (LAD), Census 2021
Severe mental illness prevalence is 1.4% (493 patients), matching Brighton and Hove (LAD) (1.4%) and above NHS Sussex Integrated Care Board (1.1%) and England (1.0%). Learning disability prevalence is 0.6% (211 patients), matching all benchmarks. Catchment services cover 19 care homes with 484 beds. The SMI register is above the England rate, so physical-health checks for this cohort are the key workload to protect.
Severe mental illness: physical health checks
SMI blood pressure checks reach 78.3% (England 83.4%), spanning 65.6% at Brighton Station Health Centre and 71.8% at School House Surgery. BMI recording is 75.4% (England 82.1%) and alcohol recording is 72.0% (England 81.8%).
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
3,893
Hypertension register
+10.77%
Register growth, 3 yrs
Brighton and Hove (LAD) +7.27% · England +5.60%
+4.62pp
BP control, under 80
≤140/90 · +2.02pp aged 80+
+853
More patients by 2030
Forecast 4,746 (13.07%)
Hypertension case-finding and control
Hypertension QOF prevalence is 10.7% (3,893 patients), in line with Brighton and Hove (10.5%) but below NHS Sussex Integrated Care Board (16.3%) and England (15.2%), though crude prevalence is not age-adjusted. Blood pressure recording is high at 94.1%, exceeding the borough (88.6%), ICB (90.2%) and England (90.0%). However, treatment to target reaches 69.0%, trailing England (70.3%) and the ICB (69.1%) despite exceeding the borough (66.5%), with blood pressure controlled to <= 140/90 mmHg in 67.2% of patients aged under 80 (England 67.8%). Treatment to target lags national benchmarks despite strong blood pressure monitoring, so prioritising medication escalation for uncontrolled patients is the key operational opportunity.
Lipids and statins
Patients with QRISK >= 20% on lipid-lowering therapy reach 61.8%, above the borough (58.9%) and ICB (60.0%) but below England (63.6%). Fewer at-risk patients receive lipid-lowering therapy than national rates imply, making proactive recall for high QRISK patients the immediate priority.
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 45,524 | £2.30 | £2.42 | £1.86 | £104,705 |
| Cardiovascular (all), 2025 | 65,254 | £2.96 | £3.32 | £3.33 | £193,152 |
In 2026, the PCN prescribed 45,524 lipid-modifying items at £2.30 per item, below Brighton and Hove (£2.47) and NHS Sussex Integrated Care Board (£2.42) but above England (£1.86), spending £20,031 more than at England's unit cost. Higher unit cost than England highlights an opportunity to review lipid-modifying formulary choices where clinically appropriate.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
+5.90%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
+4.24%
Asthma prevalence, PCN 3-yr % change
Asthma prevalence is 5.7% (2,024 patients), with annual review coverage at 62.8% (England 65.7%; Brighton and Hove 60.1%), leaving about 750 patients without a recorded review. Meanwhile, asthma prescribing for ages 5-19 reaches 1,728 items per 1,000 (England 1,488), yet youth second-hand smoke recording is 70.8% (England 78.8%). COPD prevalence is 1.6% (596 patients) with 76.2% reviewed (England 76.4%). High youth prescribing alongside review gaps could indicate uncontrolled disease, which clinical review would test.
Cancer register and children's immunisation
The cancer register records 1,167 patients (3.2% prevalence, England 3.8%). Childhood immunisations lag behind the 95.0% target: MMR dose 1 coverage at 24 months is 81.8% (13.2 pp below target; England 88.3%), and the 4-in-1 booster at age 5 is 81.4% (13.6 pp below target; England 80.9%). At age 5, second-dose MMR is 83.1% against 89.8% for first dose (a 6.7 pp dose gap).
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
58.5%
Sussex ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~1,360
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Sussex ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Prostate | 56.6% | 53.2% | 19% | 1,668 |
| Breast | 86.1% | 85.4% | 23% | 1,400 |
| Bowel | 49.8% | 47.0% | 26% | 1,133 |
| Lung | 30.3% | 33.8% | 15% | 1,058 |
| Skin cancer | 95.3% | 87.8% | 17% | 698 |
In NHS Sussex ICB in 2022, 58.5% of staged cancers (4,799 of 8,209) were diagnosed at stage 1 or 2, above England (55.3%) but below the 75.0% national ambition by 16.5 pp, with stage known for 64.3% of registrations (England 67.0%). Closing this gap across the ICB would require about 1,360 additional early diagnoses. Cervical early-stage diagnosis in the ICB is 58.2% (England 67.6%). Locally, cervical screening in women aged 25-49 is 54.8% (Brighton and Hove 60.5%, England 66.8%) and breast screening is 61.9% (England 69.9%).
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In July 2026 (provisional), University Hospitals Sussex NHS Foundation Trust achieved 65.2% on the cancer 62-day standard, trailing the 85.0% standard by 19.8 pp, below NHS Surrey and Sussex ICB (71.5%) and England (71.2%). East Sussex Healthcare NHS Trust reached 67.0% and Surrey and Sussex Healthcare NHS Trust reached 70.0%. The 28-day faster diagnosis standard was 74.0% (standard 75.0%), and the 31-day combined standard was 76.8% (standard 96.0%). Diagnostics show 5.6% waiting 6+ weeks for MRI and 8.6% for CT (England 21.4% and 9.9%). These figures reflect trust performance rather than exclusive PCN pathways.
| Pathways within standard (%) | Sussex | East Sussex Healthcare | Surrey and Sussex Healthcare | Surrey and Sussex ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 74.01 | 84.20 | 77.74 | 79.29 | 79.32 |
| 31-day treatment (96%) | 76.79 | 98.19 | 96.20 | 90.45 | 92.50 |
| 62-day referral to treatment (85%) | 65.20 | 67.04 | 69.97 | 71.51 | 71.16 |
| Diagnostic waits over 6 weeks (%) | Sussex | East Sussex Healthcare | Surrey and Sussex Healthcare | England |
|---|---|---|---|---|
| MRI | 5.62 | 6.48 | 27.53 | 21.40 |
| CT | 8.57 | 0.48 | 18.49 | 9.92 |
| Echocardiography | 0.39 | 21.94 | 43.78 | 28.48 |
| Colonoscopy | 39.35 | 0.74 | 15.11 | 30.83 |
| Gastroscopy | 20.02 | 0.31 | 21.06 | 29.02 |
| All 15 DM01 tests | 12.95 | 5.27 | 28.50 | 23.14 |
| Community services activity | Brighton and Hove residents | Surrey and Sussex ICB |
|---|---|---|
| Care contacts | 23,615 | 309,615 |
| Referrals | 5,590 | 66,930 |
| Patients with a contact | 7,350 | 85,660 |
Community services (residents of Brighton and Hove), Jun 2026 (provisional). In June 2026 (provisional), community health service records show 23,615 total contacts for Brighton and Hove residents, of which 14,325 contacts (60.7%) were with adults aged 65 and older. This reflects activity across the local authority rather than PCN-level activity.
Practice variation and patient experience
Phone access spans 62.7 pp between practices while clinical QOF achievement remains high
Clinical QOF achievement ranges from 95.3% at School House Surgery to 99.7% at Brighton Station Health Centre (England 97.1%). Vaccination achievement spans 40.1 pp, from 23.8% at Ship Street Surgery to 63.8% at Saltdean And Rottingdean Med Practice (England 55.2%). Personalised care adjustments reach 7.8% at Saltdean And Rottingdean Med Practice and 15.0% at School House Surgery (England 10.0%).
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Ship Street | 108 | 31.1 | 81.8% | 67.4% | 90.1% |
| Saltdean And | 100 | 0.9 | 52.4% | 72.9% | 74.2% |
| Brighton Station | 122 | 36.9 | 65.4% | 82.2% | 70.5% |
| School House | 83 | 49.1 | 50.6% | 74.7% | 68.0% |
| The Avenue Surgery | 100 | 60.5 | 19.1% | 80.7% | 59.3% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Heart failure reviews fell 2.7% over three years (England +8.7%)
Over three years, heart failure reviews fell 2.7%, trailing England's +8.7% increase by 11.4 points, though current coverage remains 81.7% (England 78.5%). Smoking cessation offers fell 2.0 pp (Brighton and Hove (LAD) +1.0 pp; England +0.1 pp). Conversely, physical checks on the mental health register improved rapidly: BMI recording rose 18.4 pp (England +5.1 pp), alcohol recording rose 17.5 pp (England +5.4 pp), and blood pressure checks rose 13.1 pp (England +4.4 pp). However, current SMI check levels (75.4% BMI, 72.0% alcohol, 78.3% BP) still lag England (82.1%, 81.8%, 83.4%).
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Heart failure reviews
Breast screening (53-70)
Dementia register
Depression register
Smoking support (SMI)
BMI record (SMI)
Alcohol record (psychosis)
BP check (SMI)
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Brighton and Hove (LAD) | Asset | PCN | Brighton and Hove (LAD) |
|---|---|---|---|---|---|
| Care homes (catchment) | 19 (484 beds) | n/a | Schools (catchment) | 48 | n/a |
| Children's centres | 4 | 14 | Places of worship | 44 | 113 |
| Libraries | 5 | 13 | Homelessness support (VCS) | 0 | no data |
| Primary schools (LA maintained) | 10 | 35 | Primary academies | 2 | 7 |
| Special schools | n/a | 2 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Structured asthma review and youth recall
Asthma review coverage is 62.8% (England 65.7%; Brighton and Hove (LAD) 60.1%) across 2,024 patients (about 750 unreviewed), while youth asthma prescribing is 1,728 per 1,000 (England 1,488). For discussion: practices could run structured asthma review and inhaler check recall using flexible after-school or holiday slots, prioritising high-deprivation lists. Moderate effort to run.
Evidence base: the annual asthma review is the process gap between the register and outcomes.
Policy anchor: Core20PLUS5 chronic respiratory disease priority.
Option 2
Combined SMI physical health check outreach
Across the 493-patient SMI register, annual blood pressure checks reach 78.3% (England 83.4%), BMI recording 75.4% (England 82.1%) and alcohol recording 72.0% (England 81.8%). For discussion: the PCN could introduce combined single-visit SMI physical check clinics, dedicated outreach for non-attenders, and liaison raised with system mental health partners. Moderate effort to run.
Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.
Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.
Option 3
Hypertension and lipid therapy escalation
On the 3,893-patient hypertension register, blood pressure recording is 94.1% (England 90.0%), but treatment to target is 69.0% (England 70.3%) and QRISK >= 20% lipid therapy is 61.8% (England 63.6%). Moderate effort to run.
Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.
Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Working age access review (p2) | Aged 18-64 | Neighbourhood health framework | PCN |
| Targeted Core20 outreach and reconciliation (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| SMI physical check recall (p4) | SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN |
| Hypertension medication escalation audit (p5) | Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Preschool immunisation outreach (p6) | MMR dose 1 coverage at 24 months | 10YHP sickness to prevention · 95% target | PCN |
| Screening recall and engagement audit (p7) | Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) | Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026 | PCN |
| Telephony and triage review (p9) | GPPS easy to contact the practice by phone | 10YHP, hospital to community | Practice |
| Option 1 · Structured asthma review and youth recall (p12) | Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Patients with Asthma (6-19 yrs): Second-hand smoking status recorded in the last 12 months (denominator incl. PCAs) | Core20PLUS5 respiratory | PCN |
| Option 2 · Combined SMI physical health check outreach (p12) | Severe mental illness register · SMI register with a BP check in the last 12 months · SMI register with a BMI recorded in the last 12 months | MHIS · From Harm to Hope | PCN & Practice |
| Option 3 · Hypertension and lipid therapy escalation (p12) | Hypertension register · Hypertension patients with a recent BP reading · Hypertension patients treated to target | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | Local authority | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
